11.49
Roivant Sciences Ltd 주식(ROIV)의 최신 뉴스
Will Roivant Sciences Ltd. outperform the marketAI Intraday Market Movement Prediction Tool - Newser
Will Roivant Sciences Ltd. see short term momentumStrong Buy Signal Summary with Entry Zone - Newser
How high can Roivant Sciences Ltd. stock goDaily Entry Opportunity Forecasting Tool - Newser
Is Roivant Sciences Ltd. stock a good hedge against inflationTechnical Reversal Pattern Summary and Tracker - Newser
Why Roivant Sciences Ltd. stock attracts strong analyst attentionBuy and Hold Strategy for Capital Safety - Newser
Roivant Sciences Earnings Expectations: A Closer Look at the Company's Performance and Analyst Sentiments - AInvest
Roivant Sciences (ROIV) to Release Earnings on Monday - Defense World
What makes Roivant Sciences Ltd. stock price move sharplyChart Driven Opportunity Scanner with Alerts - Newser
Barrick Gold, Roivant Sciences, Owens & Minor to report earnings Monday - Investing.com Australia
A Glimpse of Roivant Sciences's Earnings Potential - 富途牛牛
What To Expect From Roivant Sciences Ltd (ROIV) Q1 2026 Earnings - Yahoo Finance
Roivant Sciences Ltd. shares fall 1.12% intraday as Sumitomo Pharma submits application for Parkinson's disease treatment. - AInvest
ROIV’s Market Whiplash: 9.51% YTD Rise, 8.29% Rise in 30 Days - investchronicle.com
Published on: 2025-08-05 19:46:06 - Newser
Sector ETF Data Correlates with Strength in Roivant Sciences Ltd.Exit Ready Momentum Stock Watchlist Expanded - beatles.ru
What analysts say about Roivant Sciences Ltd. stockDynamic investment opportunities - Jammu Links News
What is the risk reward ratio of investing in Roivant Sciences Ltd. stockAchieve rapid wealth accumulation with smart picks - Jammu Links News
Why is Roivant Sciences Ltd. stock attracting strong analyst attentionMaximize returns with effective portfolio management - Jammu Links News
How does Roivant Sciences Ltd. generate profit in a changing economyTrack emerging stocks with high growth potential - Jammu Links News
What is the dividend policy of Roivant Sciences Ltd. stockCapitalize on momentum stocks early - Jammu Links News
Should I hold or sell Roivant Sciences Ltd. stock in 2025Capitalize on fast-moving stock trends - Jammu Links News
How volatile is Roivant Sciences Ltd. stock compared to the marketExceptional risk-adjusted gains - Jammu Links News
What institutional investors are buying Roivant Sciences Ltd. stockAchieve exceptional returns with expert guidance - Jammu Links News
What are analysts’ price targets for Roivant Sciences Ltd. in the next 12 monthsInvest confidently with professional market insights - Jammu Links News
Is Roivant Sciences Ltd. a growth stock or a value stockDiscover undervalued stocks before they soar - Jammu Links News
Can Roivant Sciences Ltd. hit a new high this monthTrade Plan With Low Risk High Return - Newser
Is it the right time to buy Roivant Sciences Ltd. stockChart Pattern Planner For Fast Growth - Jammu Links News
Is Roivant Sciences Ltd. showing signs of accumulationEntry Points For Growing Stocks Identified by Models - metal.it
Roivant Sciences Ltd. Building a Base Near SupportShort Term Trading Opportunity Watch Sees Shift - beatles.ru
Recovery Signals Appearing in Roivant Sciences Ltd. ChartsConsistent Income Focused Trade List Analyzed - metal.it
Is Roivant Sciences Ltd. Starting a New UptrendReal-Time Trade Insights Spark Market Reactions - metal.it
What caused the surprising earnings drop in Q2 2025 for ROIV? - AInvest
Published on: 2025-07-29 10:36:14 - metal.it
Roivant Sciences Ltd. Consolidation Zone May Signal AccumulationChart Driven High Reward Trading Setup Presented - metal.it
Roivant to Reveal Q1 2025 Financial Performance and Strategic Updates: Key Details for August 11 Earnings Call - Stock Titan
Published on: 2025-07-28 06:27:01 - jammulinksnews.com
Is Roivant Sciences Ltd. a Top Dividend Stock to Watch in 2025High Return Conservative Stocks - metal.it
Published on: 2025-07-27 16:10:26 - Jammu Links News
Is Roivant Sciences Ltd. a good long term investmentUnbelievable profit margins - Autocar Professional
Roivant Sciences (ROIV) Anticipated to Benefit from Brepocitinib Developments | ROIV Stock News - GuruFocus
Vivek Ramaswamy to welcome third child soon: Meet his wife and his two elder sons - Times of India
Goldman Sachs Resumes Roivant Sciences (ROIV) Coverage with ‘Buy’ Rating - MSN
자본화:
|
볼륨(24시간):